Brexit and the Falsified Medicines Directive

In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with […]

Brexit and Medicines

We have long been wondering what effects Brexit will have on medicine and medicines post-Brexit. The BMJ is suggesting some of the initial and obvious consequences for: staff from the EU, health coverage for travellers, air quality and public health issues.

However, Hunt did say that the UK will no longer be part of the European system for licensing medicines. What […]

January 31st, 2017|Brexit|0 Comments|